SEC Form 4 · accession 0000899243-16-033357
Wave Life Sciences, Inc. · WVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Masaharu Tanaka
Director · 10% Owner
Period of report
Nov 10, 2016
Accepted (ET)
Nov 14, 2016 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631574
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy)F1 | $36.43 | Nov 10, 2016 | A | 9,000 | A | — | Nov 10, 2021 | Ordinary Shares | 9,000 | 9,000 | D |
Explanation of responses
- F1The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on November 10, 2017.